Astellas’ Once-Daily Tacrolimus Gets Nod From Europe’s CHMP
Positive opinion comes after FDA issued a mix of “approvable” and “not approvable” decisions for three transplant claims.
Positive opinion comes after FDA issued a mix of “approvable” and “not approvable” decisions for three transplant claims.